Zevra Therapeutics, Inc. (ZVRA)
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Edesa Biotech Reports Fiscal Year 2025 Results
UTHR: Notification
GRI Bio Announces Closing of $8.0 Million Public Offering
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
Prothena - Prothena Announces Board of Directors Update
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer
4DMT Announces New Employment Inducement Grants
IM Cannabis Appoints Asi Levi as Chief Financial Officer